Literature DB >> 20037892

Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.

Vassilis Filiopoulos1, Dimitrios Hadjiyannakos, Lambrini Takouli, Polixeni Metaxaki, Vasilis Sideris, Dimosthenis Vlassopoulos.   

Abstract

PURPOSE: The impact of different dialysis modalities on oxidative stress and inflammation and the factors implicated in this interrelationship have not been adequately studied. This study was designed to comparatively evaluate the effect of hemodialysis (HD) and peritoneal dialysis (PD) on oxidative stress and inflammatory biomarkers and to search for associated factors.
METHODS: We studied 20 HD, 11 PD patients and 11 healthy controls. Calculations were based on total antioxidant capacity (TAC) and superoxide dismutase (SOD), by spectrophotometry, as oxidative stress biomarkers; and high sensitivity CRP (hs-CRP), Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), by ELISA, as inflammation biomarkers.
RESULTS: HD and PD patients showed significantly increased levels of TA C, SOD and hs-CRP compared to healthy controls. No significant difference was observed in TNF-alpha and IL-6. Compared to HD patients, PD patients showed TNF-alpha levels that were increased, although non-significantly, and significantly higher homocysteine (Hcy). No differences were observed for IL-6, hs-CRP, TA C and SOD. In HD patients, significant positive correlations were found between intact parathyroid hormone (iPTH) and TNF-alpha, and between uric acid (UA) and TAC. Beta2-microglobulin (Beta2M) was negatively correlated with TAC, total cholesterol (TC) positively with TNF-alpha and negatively with SOD, and triglycerides (TG) correlated positively with TNF-alpha. In PD patients, TG correlated positively with TNF-alpha, HDL-cholesterol negatively with TNF-alpha, LDL-cholesterol negatively with SOD, and Beta2M negatively with SOD.
CONCLUSIONS: HD and PD patients show similar degrees of inflammation and oxidative stress activation. Factors such as UA, iPTH, Beta2M and lipid profile correlate to oxidative stress and inflammatory biomarkers in both HD and PD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037892     DOI: 10.1177/039139880903201206

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  18 in total

1.  Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients.

Authors:  Nazanin Noori; Ramanath Dukkipati; Csaba P Kovesdy; John J Sim; Usama Feroze; Sameer B Murali; Rachelle Bross; Debbie Benner; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

Review 2.  Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review.

Authors:  Zeba Khan; Manoj Pandey; Ravindra M Samartha
Journal:  Int J Health Sci (Qassim)       Date:  2016-10

3.  Zinc Supplementation and Body Weight: A Systematic Review and Dose-Response Meta-analysis of Randomized Controlled Trials.

Authors:  Shima Abdollahi; Omid Toupchian; Ahmad Jayedi; David Meyre; Vivian Tam; Sepideh Soltani
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

4.  Coexistence of micro-inflammatory and macrophage phenotype abnormalities in chronic kidney disease.

Authors:  Jianhua Wu; Naifeng Guo; Xiaolan Chen; Changying Xing
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 5.  Uremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia?

Authors:  Antonia Kaltsatou; Giorgos K Sakkas; Konstantina P Poulianiti; Yiannis Koutedakis; Konstantinos Tepetes; Grigorios Christodoulidis; Ioannis Stefanidis; Christina Karatzaferi
Journal:  Front Physiol       Date:  2015-03-30       Impact factor: 4.566

6.  Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysis.

Authors:  Afsoon Emami Naini; Reza Ebrahimi Kord Asiabi; Noushin Keivandarian; Firouzeh Moeinzadeh
Journal:  Adv Biomed Res       Date:  2015-08-10

7.  Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis.

Authors:  Peter Luedike; Christos Rammos; Julia Pohl; Martin Heisler; Matthias Totzeck; Werner Kleophas; Gerd R Hetzel; Malte Kelm; Ulrike Hendgen-Cotta; Tienush Rassaf
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

8.  Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.

Authors:  Angélica Rangel-López; Maria Eugenia Paniagua-Medina; Marcia Urbán-Reyes; Martha Cortes-Arredondo; Cleto Alvarez-Aguilar; Joel López-Meza; Alejandra Ochoa-Zarzosa; Bengt Lindholm; Elvia García-López; José Ramón Paniagua
Journal:  Mutagenesis       Date:  2013-03       Impact factor: 3.000

9.  High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.

Authors:  Shou-Hsuan Liu; Yi-Jung Li; Hsin-Hsu Wu; Cheng-Chia Lee; Chan-Yu Lin; Cheng-Hao Weng; Yung-Chang Chen; Ming-Yang Chang; Hsiang-Hao Hsu; Ji-Tseng Fang; Cheng-Chieh Hung; Chih-Wei Yang; Ya-Chung Tian
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients.

Authors:  Shahram Taheri; Nooshin Keyvandarian; Firouzeh Moeinzadeh; Mojgan Mortazavi; Afsoon Emami Naini
Journal:  Adv Biomed Res       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.